Work

A phase ib trial to evaluate the safety and efficacy of quinacrine plus capecitabine in patients with refractory metastatic colorectal cancer.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e15020

Authors: Arthur Winer, Namrata Vijayvergia, Steven J. Cohen, Crystal S. Denlinger, Igor A. Astsaturov, Efrat Dotan, Jean-Nicolas Gallant, Edward W Wang, Miriam Kunkel, Bora Lim, Harold A. Harvey, Jeffrey Michael Sivik, Lanlan Zhou, Kenneth Korzekwa, Karen Ruth, Eric A. Ross, Wafik S. El-Deiry

Institutions: Fox Chase Cancer Center, Abington Memorial Hospital, Vanderbilt University Medical Center, City Of Hope National Medical Center, City of Hope, Penn State Milton S. Hershey Medical Center, The University of Texas MD Anderson Cancer Center, Temple University, Brown University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947445776

Cites:

Cited by:

Related to: 10